Pacira BioSciences' Total Liabilities fell 2612.91% to $570.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $570.4 million, marking a year-over-year decrease of 2612.91%. This contributed to the annual value of $775.2 million for FY2024, which is 1006.91% up from last year.
Per Pacira BioSciences' latest filing, its Total Liabilities stood at $570.4 million for Q3 2025, which was down 2612.91% from $779.5 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Total Liabilities ranged from a high of $1.3 billion in Q4 2021 and a low of $570.4 million during Q3 2025
Its 5-year average for Total Liabilities is $806.8 million, with a median of $767.5 million in 2024.
In the last 5 years, Pacira BioSciences' Total Liabilities skyrocketed by 10539.0% in 2021 and then tumbled by 3608.79% in 2023.
Quarter analysis of 5 years shows Pacira BioSciences' Total Liabilities stood at $1.3 billion in 2021, then crashed by 32.62% to $906.2 million in 2022, then dropped by 22.28% to $704.3 million in 2023, then rose by 10.07% to $775.2 million in 2024, then decreased by 26.42% to $570.4 million in 2025.
Its Total Liabilities was $570.4 million in Q3 2025, compared to $779.5 million in Q2 2025 and $788.1 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value